The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

N4 Pharma upbeat on recent Nuvec developments

Mon, 18th Dec 2023 11:17

(Sharecast News) - N4 Pharma updated the market on Monday on its ongoing research efforts related to Nuvec, its delivery system designed for cancer treatments and vaccines.

The AIM-traded firm said that in collaboration with the University of Queensland, it was exploring the potential of Nuvec as an oral delivery system for oligonucleotides, encompassing DNA and RNA.

Recent experiments yielded promising results, affirming the feasibility of orally administering Nuvec loaded with a DNA plasmid for ovalbumin in vivo.

The administration of Nuvec took place through an enteric-coated capsule, enabling the release of its contents in the intestinal lumen.

Subsequently, intestinal cells successfully took up the material, resulting in successful transfection and the release of newly synthesised ovalbumin.

The company said the initial experiment replicated a previous study conducted earlier in the year.

In the experiment, an enterically-coated capsule containing Nuvec loaded with a DNA plasmid for ovalbumin was administered, and protein expression was observed three days later.

However, an additional second capsule was administered on day three in the recent experiment, leading to a substantially higher peak expression level between days four and seven.

"This continued success shows that Nuvec® has the potential to be successfully used as an oral delivery system with many potential applications such as a vaccine, a product for irritable bowel disease or to treat colonic cancer among many possible examples," said chief executive officer Nigel Theobald.

"Given the complexities involved in oral delivery, this early success with Nuvec represents a potentially massive opportunity and point of difference for Nuvec and its use as a delivery system to target multiple diseases.

"With this new data, we are in the process of scoping out the next phase of work to accumulate sufficient data to enable us to focus on a specific oral application and further news on this will be announced in the new year, and we expect to make advancing Nuvec's use as an oral delivery technology a key priority for 2024.

"In the meantime, the University of Queensland will continue its work exploring the use of Nuvec as an oral delivery system for vaccines as part of our Australian Research Council funded grant with them."

At 1033 GMT, shares in N4 Pharma were up 16.13% at 0.9p.

Reporting by Josh White for Sharecast.com.

More News
14 Sep 2020 09:04

N4 Pharma plunges as Covid-19 progress stalls

(Sharecast News) - N4 Pharma lost more than a third of its value after the company said its potential Covid-19 vaccine delivery method did not produce a positive result at stage 3 of tests.

Read more
1 Sep 2020 21:35

IN BRIEF: N4 Pharma Signs Technology Transfer & Manufacturing Contract

IN BRIEF: N4 Pharma Signs Technology Transfer & Manufacturing Contract

Read more
1 Sep 2020 09:19

N4 Pharma chooses Ardena as contract manufacturing partner

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has appointed the API and nanomedicines business unit of Ardena as its contract development and manufacturing organisation partner for the technology transfer and upscaling manufacture of 'Nuvec', it announced on Tuesday.

Read more
12 Aug 2020 14:18

N4 Pharma Shares Spike 30% On Successful Covid-19 Study

N4 Pharma Shares Spike 30% On Successful Covid-19 Study

Read more
6 Jul 2020 14:13

IN BRIEF: N4 Pharma's Nuvec Shows Promise In Oral Vaccine Delivery

IN BRIEF: N4 Pharma's Nuvec Shows Promise In Oral Vaccine Delivery

Read more
28 May 2020 14:49

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

Read more
28 May 2020 09:47

N4 Pharma completes first stage proof of concept work for Nuvec

(Sharecast News) - Pharmaceutical group N4 Pharma has completed the first phase of Covid-19 proof of concept work for Nuvec, the group's novel delivery system for cancer treatments and vaccines.

Read more
18 May 2020 15:39

N4 Pharma To File Nuvec Patent Across Europe, US, Other Major Markets

N4 Pharma To File Nuvec Patent Across Europe, US, Other Major Markets

Read more
13 May 2020 14:55

N4 Pharma Raises GBP2 Million To Fund Covid-19 Research Project

N4 Pharma Raises GBP2 Million To Fund Covid-19 Research Project

Read more
13 May 2020 11:30

N4 Pharma raises ?2.03m via oversubscribed placing

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has raised ?2.03m through an oversubscribed placing of 50,731,250 new ordinary shares, it announced on Wednesday, at a price of 4p each.

Read more
24 Apr 2020 14:33

N4 Pharma Files Patent For Nuvec Opportunities In Viral Vector Market

N4 Pharma Files Patent For Nuvec Opportunities In Viral Vector Market

Read more
24 Apr 2020 09:30

N4 Pharma files for new UK patent on 'Nuvec'

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has filed a new UK patent application around both the ability of its 'Nuvec' delivery system ability to be used to manufacture viral vectors, and to make viral vectors more efficient in applications such as ex-vivo gene therapy treatments.

Read more
16 Apr 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
16 Apr 2020 14:57

UK TRADING UPDATE SUMMARY: NHS Uses Induction Healthcare's Mobile App

UK TRADING UPDATE SUMMARY: NHS Uses Induction Healthcare's Mobile App

Read more
25 Mar 2020 12:15

N4 Pharma Explores Nuvec's Potential In Covid-19 Vaccine Delivery

N4 Pharma Explores Nuvec's Potential In Covid-19 Vaccine Delivery

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.